
Even small changes in average copayment for long-term controller asthma medications can result in significant reductions in medication use and increases in healthcare services.
Even small changes in average copayment for long-term controller asthma medications can result in significant reductions in medication use and increases in healthcare services.
HEDIS-defined persistent asthma is generally consistent with survey-defined persistent asthma over a 3-year period.
Fewer short-acting agonist canisters dispensed (but not dispensing of any controller) and higher ratio of controller to total medication are associated with reduced asthma exacerbations.
Published: November 4th 2010 | Updated:
Published: May 11th 2010 | Updated:
Published: October 11th 2011 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.